FOXE1
protein-codingforkhead box E1, the group of Forkhead boxes
Gene summary
This intronless gene encodes a protein that belongs to the forkhead family of transcription factors. Members of this family contain a conserved 100-amino acid DNA-binding 'forkhead' domain. The encoded protein functions as a thyroid transcription factor that plays a role in thyroid morphogenesis. Mutations in this gene are associated with the Bamforth-Lazarus syndrome, and with susceptibility to nonmedullary thyroid cancer-4. [provided by RefSeq, Nov 2016]
- FKHL15
- TITF2
- FOXE2
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~3.5 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0009437
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0009437
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0009437
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0009437
Submitter: Laboratory for Molecular Medicine
This gene-disease relationship has undergone rapid assessment. Classifications are based on preliminary review of gene-disease validity during analysis of genomic sequencing results.
Inheritance Pattern: AR
Disease ID:MONDO:0009437
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0009437
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0009437
Submitter: ClinGen
FOXE1 was first reported in relation to AR FOXE1-related athyreosis with cleft palate in 1998 (Clifton-Bligh et al., PMID: 9697705). FOXE1-related athyreosis with cleft palate, also known as Bamforth-Lazarus syndrome, is a rare disorder characterized by congenital hypothyroidism due to thyroid agenesis or thyroid hypoplasia, cleft palate, and spiky hair. Variants in FOXE1 have been reported in individuals with the following disease entities: Bamforth-Lazarus syndrome, thyroid cancer, nonmedullary 4, and athyreosis. Per criteria outlined by the ClinGen Lumping and Splitting Working Group, we found differences in phenotypic variability and inheritance pattern. Therefore, the following disease entities have been split into three disease entities, Bamforth-Lazarus syndrome (MIM:241850), thyroid cancer, nonmedullary 4 (MIM:616534), and athyreosis (no MIM). The split curations for AD thyroid cancer, nonmedullary 4 and athyreosis will be curated separately by a different GCEP. Five missense and one frameshift variants that have been reported in six probands in six publications (PMIDs: 9697705, 12165566, 16882747, 20453517, 24219130, 35963604) are included in this curation. The mechanism of pathogenicity is unknown at this time. This gene-disease relationship is also supported by functional alteration of patient cells, animal models, and expression data (PMIDs: 9697705, 9697704, 15494458, 21177256). In summary, there is definitive evidence to support the relationship between FOXE1 and Bamforth-Lazarus syndrome. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Craniofacial Malformations GCEP on the meeting date May 16th, 2024 (SOP Version 10).
Clinical Genomic Database (CGD)
Manifestation: Craniofacial; Dermatologic; Endocrine; Musculoskeletal; Oncologic
Intervention: Endocrine; Oncologic
Rationale: For Thyroid cancer, nonmedullary 4, individuals have been described as being susceptible to nonmedullary thyroid cancer, and awareness may allow early surveillance, diagnosis, and management; For Hypothyroidism, thyroidal, with spiky hair and cleft palate (Bamforth-Lazarus syndrome), the condition may be clinically recognizable, but recognition and prompt treatment of hypothyroidism can be beneficial
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to FOXE1 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_004473.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 21 | 3 | 24 | |||
| missense | 3 | 2 | 74 | 2 | 2 | 83 |
| nonsense | 1 | 1 | ||||
| start loss | 0 | |||||
| frameshift | 1 | 1 | 2 | |||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 4 | 2 | 76 | 23 | 5 | 110 |
Highest pathogenic variant AF is 0.000006582065
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_004464.2 | 1 | MANE Select | |
| Ensembl | ENSP00000364265.3 | 1 | MANE Select |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| foxe1 | Danio rerio | Structure: ceratobranchial cartilage Quality: deformed abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Biological Process
- negative regulation of transcription by RNA polymerase II
- regulation of transcription by RNA polymerase II
- thyroid hormone generation
- anatomical structure morphogenesis
- cell migration
Molecular Function
- DNA-binding transcription factor activity, RNA polymerase II-specific
- DNA-binding transcription factor activity
- sequence-specific DNA binding
Cellular Component
- nucleus
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000375123
- Coding exons
- 1
- Length
- 3451
- Individuals with no LoFs
- 0
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 0
- Defined
- 0
- p
- 0.00
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.315 | 149 | 160 | 0.930 | 0.00000739 | 2256 |
| Missense (PolyPhen) | 55 | 63.26 | 0.86943 | 738 | ||
| Synonymous | 0.328 | 70 | 73.6 | 0.951 | 0.00000363 | 840 |
| Loss of Function | 2.11 | 0 | 5.20 | 0.00 | 2.21e-7 | 84 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0 | 0.0 | absent |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0 | 0.0 | absent |
| South Asian | 0 | 0.0 | absent |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Transcription factor that binds consensus sites on a variety of gene promoters and activate their transcription. Involved in proper palate formation, most probably through the expression of MSX1 and TGFB3 genes which are direct targets of this transcription factor. Also implicated in thyroid gland morphogenesis. May indirectly play a role in cell growth and migration through the regulation of WNT5A expression. {ECO:0000269|PubMed:12165566, ECO:0000269|PubMed:16882747, ECO:0000269|PubMed:20094846, ECO:0000269|PubMed:20484477, ECO:0000269|PubMed:21177256, ECO:0000269|PubMed:24219130, ECO:0000269|PubMed:25381600, ECO:0000269|PubMed:9697705}.;
- Disease
- DISEASE: Bamforth-Lazarus syndrome (BLS) [MIM:241850]: A disease characterized by thyroid agenesis, cleft palate and choanal atresia. {ECO:0000269|PubMed:12165566, ECO:0000269|PubMed:21177256, ECO:0000269|PubMed:24219130, ECO:0000269|PubMed:9697705}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Thyroid cancer, non-medullary, 4 (NMTC4) [MIM:616534]: A form of non-medullary thyroid cancer (NMTC), a cancer characterized by tumors originating from the thyroid follicular cells. NMTCs represent approximately 95% of all cases of thyroid cancer and are classified into papillary, follicular, Hurthle cell, and anaplastic neoplasms. {ECO:0000269|PubMed:25381600}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.106
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.325
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |